Pathogenesis of Systemic Sclerosis
Systemic scleroderma (SSc) is one of the most complex systemic autoimmune diseases. It targets the vasculature, connective tissue-producing cells (namely fibroblasts/myofibroblasts), and components of the innate and adaptive immune systems. Clinical and pathologic manifestations of SSc are the resul...
Main Authors: | Pattanaik, Debendra, Brown, Monica, Postlethwaite, Bradley C., Postlethwaite, Arnold E. |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459100/ |
Similar Items
-
Vascular involvement in systemic sclerosis (scleroderma)
by: Pattanaik, Debendra, et al.
Published: (2011) -
Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts
by: Brown, Monica, et al.
Published: (2012) -
Molecular network of important genes for systemic sclerosis-related progressive lung fibrosis
by: Jiao, Yan, et al.
Published: (2015) -
Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis
by: Akira Tokumura, Laura D. Carbone, Yasuko Yoshioka, Junichi Morishige, Masaki Kikuchi, Arnold Postlethwaite, Mitchell A. Watsky
Published: (2009-01-01) -
Notes on Enemy Bombsights
by: F., Postlethwaite
Published: (1942)